China Biologic Products EBITDA margin
Quel est le EBITDA margin de China Biologic Products?
Le EBITDA margin de China Biologic Products Holdings, Inc. est 42.45%
Quelle est la définition de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin des entreprises dans Miscellaneous secteur sur LSE par rapport à China Biologic Products
Entreprises avec ebitda margin similaire à China Biologic Products
- Legacy Housing a EBITDA margin de 42.33%
- Amerigo Resources a EBITDA margin de 42.34%
- ACNB a EBITDA margin de 42.36%
- Pharos plc a EBITDA margin de 42.37%
- Lilis a EBITDA margin de 42.40%
- Silvercorp Metals a EBITDA margin de 42.44%
- China Biologic Products a EBITDA margin de 42.45%
- United Overseas Bank (Singapore) a EBITDA margin de 42.46%
- First Bancshares Inc Miss a EBITDA margin de 42.50%
- WEC Inc a EBITDA margin de 42.51%
- National Grid Plc a EBITDA margin de 42.51%
- PetroShale a EBITDA margin de 42.52%
- Divi's Laboratories a EBITDA margin de 42.52%